Clinical Trial Update: S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study [Phase 2]

View source ↗

Summary

An open-label, single-center Phase II study from Fudan University evaluated S-1 in combination with cisplatin for recurrent or metastatic esophageal squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED